Gabarone Alternatives Compared
Gabarone (gabapentin) | Neurontin (gabapentin) | Gabapentin |
|
---|
Gabarone (gabapentin) | Neurontin (gabapentin) | Gabapentin |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Postherpetic Neuralgia. Gabarone may also be used for purposes not listed in this medication guide. |
Prescription only
Neurontin may be used in the treatment of partial-onset seizures and nerve pain but it is likely to cause dizziness or drowsiness. It requires three times daily administration because of its short... View more |
Prescription only
Gabapentin is an anticonvulsant with pain-relieving effects that may be used to treat certain seizure disorders or relieve nerve pain. Common side effects include dizziness or drowsiness and it may... View more |
Related suggestions Postherpetic Neuralgia
|
|||||||||||||||
More about Gabarone (gabapentin) | More about Neurontin (gabapentin) | More about Gabapentin | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Gabarone has an average rating of 4.5 out of 10 from a total of 4 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 25% reported a negative effect. |
Neurontin has an average rating of 7.3 out of 10 from a total of 195 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 13% reported a negative effect. |
Gabapentin has an average rating of 7.2 out of 10 from a total of 2556 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Neurontin prices |
View all Gabapentin prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other gabapentin brands include: Fanatrex, Gralise, Neurontin | Other gabapentin brands include: Fanatrex, Gabarone, Gralise | Fanatrex, Gabarone, Gralise, Neurontin | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
6 hours |
6 hours |
6 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 270 drugs are known to interact with Gabarone:
|
A total of 270 drugs are known to interact with Neurontin:
|
A total of 270 drugs are known to interact with Gabapentin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
December 30, 1993 |
December 30, 1993 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.